This inventor holds 1 USPTO granted patent. Top assignee: Fresenius Medical Care Affina Gmbh. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Manuela Dierenfeld
Introduction
Manuela Dierenfeld, an accomplished inventor based in Blankenfelde, Germany, has made significant contributions to the field of medical innovation. With a focus on combating dilatative cardiomyopathy (DCM), her work stands out in the realm of therapeutic peptides. Dierenfeld is not only recognized for her groundbreaking patent but also for her collaborative efforts within the medical field.
Latest Patents
Dierenfeld holds a patent for "Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy." This innovative patent describes peptides that specifically bind to auto-antibodies implicated in the pathological relationships with DCM. Notably, these peptides can be linked to a solid phase, allowing for the removal of harmful auto-antibodies from the blood of patients suffering from DCM. This advancement offers a promising approach to treating this severe cardiac condition.
Career Highlights
Manuela Dierenfeld's professional journey is marked by her role at Fresenius Medical Care Affina GmbH, where she has utilized her expertise to drive forward innovative solutions in patient care. Her dedication to research and development within the medical device industry has established her as a notable figure in the field.
Collaborations
Collaboration is key in the world of innovation, and Dierenfeld has worked alongside esteemed colleagues such as Wolfgang Rönspeck and Rudolf Kunze. Together, they have contributed to advancing medical treatments and enhancing the quality of care for patients with complex health conditions.
Conclusion
In summary, Manuela Dierenfeld exemplifies the spirit of innovation in the medical field through her significant patent on peptides aimed at treating dilatative cardiomyopathy. Her work at Fresenius Medical Care Affina GmbH and her collaborative efforts underscore the importance of teamwork and ingenuity in developing effective solutions for challenging health issues. Through her ongoing contributions, Dierenfeld continues to inspire the next generation of inventors and medical professionals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile